Our findings, which demonstrate the relationship between SGLT2 inhibition and H2S formation, highlight a novel mechanism regarding the antioxidant and neuroprotective effects of EMPA against diabetes-related cognitive impairment. The gene discussed is SLC5A2; the disease is Cognitive impairment.